Brief: Viracta Therapeutics Reports Fourth Quarter And Full Year 2023 Financial Results And Provides Business Update

Viracta Therapeutics

07/03/2024 21:51

March 7 (Reuters) - Viracta Therapeutics Inc  VIRX.O :
    * VIRACTA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2023
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * VIRACTA THERAPEUTICS INC - CASH, CASH EQUIVALENTS, AND
SHORT-TERM INVESTMENTS TOTALED APPROXIMATELY $53.7 MILLION AS OF
DECEMBER 31, 2023
    * VIRACTA THERAPEUTICS INC - PRO FORMA FOR BUSINESS
TRANSACTIONS,
OUR CASH RUNWAY TO FUND OPERATIONS IS EXTENDED INTO MID-Q1 2025.

Source text for Eikon:  ID:nGNX9kM3TB 
Further company coverage:  VIRX.O